The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Special https://ift.tt/2EntxSq
Subscribe to:
Post Comments (Atom)
RBI moves to suck out excess liquidity
As Forex Reserves Swell To All-Time High Of $786Bn, RBI Announces Sale Of 1L Cr Bonds from Business News Today: Stock Markets, Financial N...
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
The buzz in Telangana is that Chief Minister K Chandrashekar Rao, who has ambitions of a role in national politics, could resign in favour o...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
No comments:
Post a Comment